CHA AI Healthkare

At a glance

CHA AI Healthkare filed 57 disclosures in the last 12 months, including 12 5% holder, 2 contract, 2 insider and 2 m&a. The most recent key filing was on Aug 14: 10%+ shareholder's holding rose by 2,886,296 sh (other change).

Revenue for 2025 was ₩7.3B, down 53.4% on 2024. It made an operating loss of ₩7.5B. Debt was 46% of equity at year end. The latest interim report (2026 H1) shows revenue of ₩4.8B and operating loss of ₩3.5B.

The 2025 annual report lists 44 employees with an average tenure of 3.1 years and average pay of ₩45.6M. Its 13 directors and auditors were paid ₩14.2M each on average. It paid no cash dividend for 2025. 메타엑스1호조합 and related parties held 71.23% at year end.

Of 5 recent 5%+ holder reports, 3 raised and 2 cut a stake; the largest stake reported was 71.23% on Aug 14.

From the 2025 annual report

Staff: 44 (25 men, 19 women), of whom 1 on fixed-term contracts. Total pay for the year: ₩2B. Directors and auditors: 13, paid ₩185.2M in total.

No cash dividend was paid for 2025.

Largest shareholder

메타엑스1호조합 holds 71.23%; with 0 related parties the group holds 71.23% of common shares at year end (from 0.00% at the start of the year).

Auditor: 삼정 회계법인 · opinion: Unqualified.

Source: 2025 annual business report (DART). How figures are combined

New contracts, last 12 months

2 new supply contracts worth 737% of the revenue stated in the filings.

Amended amounts replace the originals. Subsidiary contracts and terminations are excluded.

Financial summary

5%+ holder reports